Head of Sales - US Oncology

The Role Moderna continues to expand its innovative mRNA platform, unlocking new applications across diseases and therapeutic areas. As the company advances its oncology pipeline, including a personalized mRNA therapy intismeran autogene in collaboration with Merck, this role will play a critical part in launching Moderna’s first commercial therapeutic into the oncology market.  Moderna is seeking a Head of Sales, Oncology, who will establish, lead, and scale the U.S. Oncology Sales organization and drive field strategy and execution for a co-promoted solid tumor oncology asset operating within a joint commercialization and governance model.  This role is accountable for national sales performance, oncology launch excellence, and field execution across complex account ecosystems, while partnering closely with an alliance counterpart to ensure aligned strategy, compliant operations, and differentiated customer engagement. The role requires deep expertise in oncology account dynamics, regimen‑based decision making, and multi‑stakeholder selling, as well as proven leadership in alliance or matrixed environments. You combine strong sales and people leadership expertise with deep oncology knowledge and are comfortable partnering with alliances or other matrix partners to drive solutions that are best for patients and business. You are a collaborative thinker who thrives in complex, cross-functional environments and brings a proactive mindset. Here’s What You’ll Do Establish and lead the U.S. Oncology Sales organization, including field force design, operating model, launch execution, performance management, and long-range capability build Lead through regional sales leaders and/or sales managers to deliver national oncology launch objectives and sales performance Serve as the senior accountable sales leader for U.S. Oncology within the co-commercialization model, partnering with Marketing, Market Access, Medical, Analytics, and Alliance leadership to shape and execute launch strategy Own sales resource planning, territory design, field KPIs, incentive input, and executional priorities for the U.S. Oncology sales organization Be responsible for motivating, managing and developing the skill sets and overall performance of the sales representatives in their respective geographies Own national sales performance for solid tumor indications, including: Quarterly sales targets and annual growth goals Account penetration and depth, and site activation strategy and execution Regimen adoption and sequencing strategy Pull‑through in competitive IO and combo landscapes Translate joint brand and medical strategy into clear field execution priorities tailored to tumor type and line of therapy. Serve as the primary U.S. field sales interface with the alliance partner’s oncology sales leadership Drive alignment on: Account targeting, SOV, and call plans (shared vs. owned accounts) Messaging within approved label and promotional boundaries Field KPIs, incentives, and performance reporting Alliance culture Represent Sales in Joint Steering Committee (JSC) and sub‑team governance forums, escalating and resolving executional issues. Lead pre‑launch and launch readiness for solid tumor indications, including: Oncology‑appropriate territory design (IDN‑, center‑, and KOL‑weighted) Recruiting and onboarding of experienced oncology reps Joint training with alliance partner (MOA, data, regimen positioning) Ensure seamless coordination with Medical, Marketing, and Market Access on launch execution and post‑launch optimization. Ensure field teams effectively navigate: Multidisciplinary decision making (oncologists, pharmacists, tumor boards) Pathway inclusion, sequencing, and combination adoption Effectively navigating access and reimbursement barriers common in oncology Here’s What You’ll Need (Basic Qualifications)   12+ years of biopharma commercial experience with deep oncology focus, including: ≥7 years in oncology sales leadership National or senior regional leadership experience required Proven track record of: Solid tumor launches (competitive or first‑in‑class) Alliance, co‑promotion, or matrixed commercial models Strong understanding of: Oncology account ecosystems and KOL dynamics Regimen‑based adoption and sequencing Market access and pathway dynamics in oncology Experience in IO, targeted therapy, or combination regimens strongly preferred. Strong familiarity with the oncology market dynamics, IDNs, and community GPO ecosystems Knowledge of oncology-specific datasets covering market landscape, competitive intelligence, real-world product utilization, prescription behavior etc. Here’s What You’ll Bring to the Table (Preferred Qualifications) Oncology‑credibility with ability to influence senior external and internal stakeholders Strong alliance mindset; able to lead through shared ownership and complexity Data‑driven, execution‑focused, and comfortable making trade‑offs in key decisions Talent magnet with a strong coaching and development philosophy Strong expertise in oncology launches, particularly novel therapeutics, with an ability to educate internal decision makers Strategic thinking skills with the ability to synthesize complex data and insights into clear, actionable recommendations for field teams or executive interactions Proven ability to partner cross-functionally and influence stakeholders across R&D, Commercial, and Finance and other key stakeholders Advanced analytics capabilities including how to effectively measure launch success Strong communication and presentation skills to effectively present insights and recommendations to executive leadership Curiosity mindset in applying latest technological developments, including GenAI, to enhance our GTM model and customer interactions A passion for contributing to a transformative company that is Bold, Relentless, Curious, and Collaborative. Pay & Benefits At Moderna, we believe